| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | n/a |
| Number of Subjects | 20 |
| Sex | n/a |
CoQ10 supplementation in a population of persons with fibromyalgia given 300mg daily for 3 months was able to reduce levels of lipid peroxidation and pro-oxidative markers in the serum, and vicariously though this (hypothesized due to correlations) reductions were seen in headaches associated with fibromyalgia by correcting abnormal markers of metabolism.
